Full Text
Cost-Effectiveness of Niraparib Versus Routine Surveillance and Olaparib for the Maintenance Treatment of Adult Patients with Ovarian Cancer in the United States

Abstract

Authors

M Fisher H Guy L Walder

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×